Martin Scherer

Martin Scherer (* born 27 July 1972 in

general practice and primary care. He is director of the Department of General practice and Primary care and head of the Division of Primary Medical Care at the University Medical Center Hamburg-Eppendorf.^[1] Since 2015 he is vice president of the German College of General Practitioners and Family Physicians (DEGAM) and since 2006 speaker of the Clinical Guidelines Committee.^[2]

Biography

From 1993 until 1999 Scherer studied medicine in Marburg,

Primary Medical Care and head of the division of general medicine at the University Medical Center Hamburg-Eppendorff.^[1] Furthermore, he is editor of the Hamburger Ärzteblatt.^[4]

Scientific contribution

One of Scherer's scientific focus is to further develop methods in Health care research. Goal is to develop indicators which can be used to measure quality in health care provision.^[5] Furthermore, Scherer is working on systematic surveys and meta-analyses. Through randomized controlled trials high levels of medical evidence are developed to trace the effectiveness of medical and diagnostic measures.^[6] As a speaker of DEGAM, Scherer is dealing with the development of guidelines. Another focus of Scherer is multimorbidity.^[7]^[8]^[9] Scherer is Co-Principal Investigator in several studies. In the MultiCare Claims Study, which is supported by the Federal Ministry of Education and Research (Germany), Scherer and Hendrik van den Bussche are investigating whether single illnesses and their interaction are relevant in terms of multimorbidity or whether it is rather the subjective consequences for patients. Together with Wolfgang Maier and Steffi Riedel-Heller, he is carrying out the AgeCoDe-Study about dementia.^[10]^[11] Scherer is Principal Investigator of the RECODE-study on heart failure. Furthermore, he is working on a guideline which aims to contribute to avoidance of over-, under provision in health care.

Memberships in scientific organisations

Scherer is member of various scientific organizations.

Member of the Guideline Commission of the Association of the Scientific Medical Societies in Germany (AWMF)
Member of the scientific advisory board of the AQUA- Institute on Applied Quality Improvement and Research in Healthcare^[12]
Member of the scientific advisory board of the Journal for Evidence and Quality in Health Care (ZEFQ)
Executive Board, European Cardiovascular Society (EPCCS)
European council on cardiovascular primary care, European Society of Cardiology (ESC)
Member of the scientific advisory board of the Versorgungsatlas of the Central Research Institute of Ambulatory Health Care^[13]

Publications

References

^ ^a ^b Martin Scherer at the University Medical Center Hamburg-Eppendorf
^ "Martin Scherer, Spokesman for the Standing Committee of DEGAM". Archived from the original on 2017-11-10. Retrieved 2016-05-30.
^ Appointments of professors, University of Lübeck
^ Hamburger Ärzteblatt
^ Herzberg H, Bernateck K, Welti F, Joos S, Pohontsch N, Blozik E, Scherer M. Patientenbeteiligung bei der Entwicklung von Qualitätsindikatoren am Beispiel der Nationalen VersorgungsLeitlinie Chronische Herzinsuffizienz - Eine qualitative Analyse kollektiver Sichtweisen. GESUNDHEITSWESEN. 2015
^ Kötter T, da Costa B, Fässler M, Blozik E, Klaus L, Jüni P, Reichenbach S, Scherer M. Metamizol-assoziierte unerwünschte Arzneimittelwirkungen: Eine systematische Übersicht mit Metaanalyse.ZFA Z Allg Med. 2016;2016(92):72-78
^ Löffler C, Altiner A, Streich W, Stolzenbach C, Fuchs A, Drewelow E, Hornung A, Feldmeier G, van den Bussche H, Kaduszkiewicz H. Multimorbidität aus Hausarzt- und Patientensicht. Z GERONTOL GERIATR. 2015
^ von dem Knesebeck O, Scherer M, Bussche van den H, Schäfer I. Zusammenhang von sozialem Status und Multimorbidität. Hamburger Ärzteblatt. 2015;69(6):12-15
^ Hansen H, Pohontsch N, Bussche van den H, Scherer M, Schäfer I. Reasons for disagreement regarding illnesses between older patients with multimorbidity and their GPs - a qualitative study. BMC FAM PRACT. 2015;16(1):68
^ Roehr S, Luck T, Heser K, Fuchs A, Ernst A, Wiese B, Werle J, Bickel H, Brettschneider C, Koppara A, Pentzek M, Lange C, Prokein J, Weyerer S, Mösch E, König H, Maier W, Scherer M, Jessen F, Riedel-Heller S. Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly - Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe).PLOS ONE. 2016;11(1):e0147050.
^ Heser K, Wagner M, Wiese B, Prokein J, Ernst A, König HH, Brettschneider C, Riedel-Heller SG, Luppa M, Weyerer S, Eifflaender-Gorfer S, Bickel H, Mösch E, Pentzek M, Fuchs A, Maier W, Scherer M, Eisele M, AgeCoDe Study Group. Associations between Dementia Outcomes and Depressive Symptoms, Leisure Activities, and Social Support. In: Dementia and Geriatric Cognitive Disorders extra, Band 4, Nr. 3, 2015; 481-93
^ AQUA- Institute on Applied Quality Improvement and Research in Healthcare
^ Versorgungsatlas of the Central Research Institute of Ambulatory Health Care

External links

[a-1] Martin Scherer at the University Medical Center Hamburg-Eppendorf

[b-2] "Martin Scherer, Spokesman for the Standing Committee of DEGAM". Archived from the original on 2017-11-10. Retrieved 2016-05-30.

[3] Appointments of professors, University of Lübeck

[f-4] Hamburger Ärzteblatt

[5] Herzberg H, Bernateck K, Welti F, Joos S, Pohontsch N, Blozik E, Scherer M. Patientenbeteiligung bei der Entwicklung von Qualitätsindikatoren am Beispiel der Nationalen VersorgungsLeitlinie Chronische Herzinsuffizienz - Eine qualitative Analyse kollektiver Sichtweisen. GESUNDHEITSWESEN. 2015

[6] Kötter T, da Costa B, Fässler M, Blozik E, Klaus L, Jüni P, Reichenbach S, Scherer M. Metamizol-assoziierte unerwünschte Arzneimittelwirkungen: Eine systematische Übersicht mit Metaanalyse.ZFA Z Allg Med. 2016;2016(92):72-78

[7] Löffler C, Altiner A, Streich W, Stolzenbach C, Fuchs A, Drewelow E, Hornung A, Feldmeier G, van den Bussche H, Kaduszkiewicz H. Multimorbidität aus Hausarzt- und Patientensicht. Z GERONTOL GERIATR. 2015

[8] von dem Knesebeck O, Scherer M, Bussche van den H, Schäfer I. Zusammenhang von sozialem Status und Multimorbidität. Hamburger Ärzteblatt. 2015;69(6):12-15

[9] Hansen H, Pohontsch N, Bussche van den H, Scherer M, Schäfer I. Reasons for disagreement regarding illnesses between older patients with multimorbidity and their GPs - a qualitative study. BMC FAM PRACT. 2015;16(1):68

[10] Roehr S, Luck T, Heser K, Fuchs A, Ernst A, Wiese B, Werle J, Bickel H, Brettschneider C, Koppara A, Pentzek M, Lange C, Prokein J, Weyerer S, Mösch E, König H, Maier W, Scherer M, Jessen F, Riedel-Heller S. Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly - Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe).PLOS ONE. 2016;11(1):e0147050.

[11] Heser K, Wagner M, Wiese B, Prokein J, Ernst A, König HH, Brettschneider C, Riedel-Heller SG, Luppa M, Weyerer S, Eifflaender-Gorfer S, Bickel H, Mösch E, Pentzek M, Fuchs A, Maier W, Scherer M, Eisele M, AgeCoDe Study Group. Associations between Dementia Outcomes and Depressive Symptoms, Leisure Activities, and Social Support. In: Dementia and Geriatric Cognitive Disorders extra, Band 4, Nr. 3, 2015; 481-93

[12] AQUA- Institute on Applied Quality Improvement and Research in Healthcare

[13] Versorgungsatlas of the Central Research Institute of Ambulatory Health Care

[1]

[2]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

Authority control databases
International	VIAF
National	Germany